Cannabis Market in Indiana

Indiana has one of the most restrictive cannabis policies in the United States. The state has no medical marijuana program and no recreational cannabis market. The only legal cannabis-related products are hemp-derived CBD oils and products containing no more than 0.3% THC, which were explicitly legalized under SEA 516 in 2018, aligning with the federal 2018 Farm Bill.

Multiple bills to establish a medical cannabis program have been introduced in the Indiana General Assembly over the years, but none have advanced to passage. The state's conservative legislative leadership has been reluctant to embrace cannabis reform despite growing bipartisan public support for at least medical legalization. Indiana remains one of the few states in the Midwest without any form of medical cannabis program.

The lack of a legal cannabis market in Indiana is particularly notable given the state's geographic position. Indiana is surrounded by states with active cannabis programs — Illinois and Michigan have recreational markets, Ohio has an expanding medical and recreational program, and Kentucky has a medical program. This proximity drives significant cannabis tourism revenue out of Indiana and into neighboring states. The CBD-only market generates modest retail revenue through health food stores, convenience stores, and online sales, but the estimated market size is minimal compared to states with established cannabis programs. No MSOs operate in Indiana due to the absence of a licensing framework.

The Indiana cannabis market is regulated by the N/A — No cannabis licensing program, which oversees licensing, compliance, and enforcement for all cannabis businesses operating within the state. The regulatory body is responsible for issuing and renewing licenses, conducting inspections, enforcing packaging and labeling requirements, managing the seed-to-sale tracking system, and handling complaints and disciplinary actions.

The current tax structure for cannabis in Indiana is: N/A — No cannabis program; standard sales tax applies to CBD products. Tax policy plays a critical role in determining the competitiveness of the legal cannabis market relative to the illicit market. States with excessively high tax rates often see consumers shift to unlicensed sources, while states with moderate rates tend to achieve higher legal market capture. Operators in Indiana must also comply with comprehensive regulatory requirements including testing, labeling, advertising restrictions, and security protocols.

Investors considering exposure to the Indiana cannabis market should evaluate several factors. The state's medical legal status, estimated market size of $10M, and limited MSO presence all influence the investment landscape. Market maturity, competitive dynamics, and regulatory stability are important considerations when evaluating companies with Indiana operations.

Cannabis stocks carry significant risks including federal illegality, regulatory uncertainty, limited access to banking services, and high tax burdens under IRC Section 280E. State-level factors such as license availability, tax rates, and enforcement against the illicit market can materially impact the profitability of licensed operators. Investors should consider a company's overall state portfolio diversification rather than relying on exposure to any single state market. Past performance does not guarantee future results, and cannabis investments may not be suitable for all investors.